Axplora expands in India
Submitted by:
Andrew Warmington
Axplora has announced a “significant” investment at its site in Vizag, India (pictured)
Esteve acquires Regis
Submitted by:
Andrew Warmington
Barcelona-based Esteve Química has acquired Regis Technologies, a hitherto privately owned CDMO headquartered in Chicago
Barcelona-based Esteve Química has acquired Regis Technologies, a hitherto privately owned CDMO headquartered in Chicago, and
Ofichem buys site in Sweden
Submitted by:
Andrew Warmington
Netherlands-based CDMO Ofichem has acquired Meribel Pharma Solutions’ former Recipharm site in Uppsala, Sweden, which
Axplora to further expand Farmabios
Submitted by:
Andrew Warmington
Axplora is to invest a further €35 million to expand its Farmabios site in Gropello
Nucleic acid API boost
Submitted by:
Andrew Warmington
Nippon Shokubai is to expand its GMP capacity for nucleic APIs tenfold It will install
Flamma opens in China
Submitted by:
Andrew Warmington
Italian CDMO Flamma Group has officially opened its new cGMP plant at Dalian, China, where
GL Chemtec completes kilo lab
Submitted by:
Andrew Warmington
CDMO GL Chemtec has announced the completion of a cGMP kilo lab at Oakville, Ontario
CDMOs in ADC investments
Submitted by:
Andrew Warmington
Five CDMOs across the world have separately announced investments in antibody-drug conjugates (ADCs). Piramal Pharma is
Feature article - The great pharma supply chain realignment
Submitted by:
Andrew Warmington
Alex Del Priore, senior vice-president of manufacturing services at Syngene, looks at the role India
Halozyme abandons Evotec bid
Submitted by:
Andrew Warmington
San Diego-based biopharmaceutical company Halozyme Therapeutics has withdrawn the offer it made for Evotec after